JPRN-UMIN000004561已完成2 期
A phase II study of Erlotinib for elderly patients previously treated non-small cell lung cancer without epidermal growth factor receptor mutation - A phase II study of Erlotinib for elderly patients previously treated non-small cell lung cancer without epidermal growth factor receptor mutation
Fukushima Medical University, cancer center0 个研究点目标入组 44 人开始时间: 2010年11月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with active lung disease such as interstitial pneumonia, pneumoconiosis, active radiation pneumonitis,or drug-induced pneumonitis 2)Patients with massive pleural or pericardial effusion,or ascites 3)Patients with active severe infections 4)Cases with past history of administration of HER related agents 5) Impossible cases with oral administration 6)Patients with active opthalmological disease 7)Patients with current or previous (within one year) history of gastrointestinal perforation 8)Patients with uncontrollable gastrointestinal ulceration 9)Pregnancy or lactation 10)Patients with symptomatic brain metastasis 11)Patients with active concomitant malignancy 12)Patients with uncontrollable diabetes mellitus 13)Patients with uncontrollable complications 14)Inappropriate patients for this study judged by the physicians
研究者
相似试验
已完成
2 期
Phase II study of erlotinib monotherapy for elderly patients with untreated advanced non-small cell lung cancer, 75 years-old or older, and positive EGFR mutation status (OSAKA-LCSG1303)non-small cell lung cancerJPRN-UMIN000011472OSAKA-LCSG31
已完成
2 期
PhaseII trial of erlotinib for elderly patients with advanced or recurrent non-small cell lung cancerJPRN-UMIN000001873Keio University School of Medicine Division of Pulmonary Medicine40
已完成
2 期
Multicenter PhaseII trial of erlotinib for elderly patients with advanced or recurrent non-small cell lung cancer.elderly patients with refractory or recurrent non-small cell lung cancer non-small cell lung cancerJPRN-UMIN000003271ung Oncology Group in Kyushu, Japan (LOGIK)44
招募中
不适用
Efficacy and safety of erlotinib in elderly patients with non-small-cell lung cancer harboring epidermal growth factor receptor mutationsnon-small-cell lung cancerJPRN-UMIN000012056Shimane university hospital38
已完成
不适用
Efficacy and safety of erlotinib in elderly patients with non-small-cell lung cancer without epidermal growth factor receptor mutations: A phase 2 trial.JPRN-UMIN000010526Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine42